Form 8-K - Current report:
SEC Accession No. 0001437749-21-022843
Filing Date
2021-09-29
Accepted
2021-09-29 16:17:57
Documents
13
Period of Report
2021-09-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20210929_8k.htm   iXBRL 8-K 26572
  Complete submission text file 0001437749-21-022843.txt   161751

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20210923.xsd EX-101.SCH 3593
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20210923_def.xml EX-101.DEF 11804
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20210923_lab.xml EX-101.LAB 15848
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20210923_pre.xml EX-101.PRE 12019
6 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20210929_8k_htm.xml XML 2637
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 211291890
SIC: 2834 Pharmaceutical Preparations